Glow Stack (BPC-157, TB-500 & GHK-Cu) | 70mg

Glow Stack is a co-formulated research blend of three distinct synthetic compounds — BPC-157, TB-500 and GHK-Cu — supplied as a single 70mg vial for in-vitro laboratory work.

${RUO_NOTE}

What is actually in the vial

The name describes a formulation, not a molecule. Three chemically unrelated entities share one container, and each behaves differently in analysis, in solution and on a certificate.

Because three species coexist, nothing about the blend can be inferred from single-peptide literature or single-peptide documentation. Treat it as its own article with its own lot history.

Where Glow sits in the blend family

Three overlapping stack names share the same catalog lineage, and the difference between them is purely additive:

Nothing else distinguishes them. Single-compound vials are listed separately as BPC-157, TB-500 and GHK-Cu.

The blue tell: a free identity check

A correctly complexed GHK-Cu solution is visibly blue. Copper(II) held by the glycine alpha-amino nitrogen, the deprotonated amide nitrogen and the histidine imidazole nitrogen of the tripeptide absorbs in the red end of the visible range, and the eye sees what is left.

This check applies to the material in solution, whichever way the product ships: to the vial as received if it arrives as a liquid, or to the solution after dissolution if it arrives as a dry cake. Either way, a Glow-labeled solution that is colorless is telling you that something in the formulation is not what the label says.

Read the limits of that check honestly. Color confirms that copper is present and coordinated. It does not report how much, it does not report purity, and it says nothing at all about the BPC-157 or TB-500 fractions sharing the vial. It rules a batch out; it never rules one in.

Pre-mixed solution versus lyophilized vial

Peptide articles reach a laboratory either as a lyophilized cake for dissolution on the bench or already in solution. Neither format is inherently better; they fail in different places.

Confirm the format before you plan around it. Catalog banners, category pages and third-party listings describe stack products inconsistently, and the format stated for this item is the only one that governs what arrives. Read the product listing itself, and if it is ambiguous, ask before ordering rather than after.

What a co-formulation buys you, and what it costs

The case for a blend is straightforward. If your study design calls for the three compounds together, one vial means one lot number, one storage condition, one preparation event and one set of handling variables instead of three. Fewer preparation steps means fewer places for technique to introduce variance between replicates.

The costs are equally concrete, and they are the reason to consider singles instead:

• You cannot vary one component independently. Any ratio question, or any control that omits one component, requires separate vials.
• The certificate characterizes the co-formulation, not each peptide separately. A single purity figure for a three-peptide mixture is a different claim from three individual purity figures, and co-elution in a mixed chromatogram can hide what a single-analyte run would show.
• Attribution is impossible. If a result looks anomalous, a blend gives you no way to say which component the anomaly belongs to.

If your protocol needs per-peptide certification, buy the singles and combine them yourself under your own documentation.

Reading the certificate for a blend

For mixtures, apply a stricter standard than you would to a single peptide. Our documentation is on the COA page. Whoever you buy from, check:

1. Lot-specific, not representative. The lot on the certificate must match the lot printed on the vial you received. A "sample COA" is a template.
2. Identity per component. Mass spectrometry should show an observed mass against a theoretical mass for each peptide present, not one aggregate statement.
3. Chromatograms, not just numbers. A purity percentage without the trace is unverifiable. For a blend you want to see the peaks resolved and assigned.
4. Copper accounted for. GHK-Cu content should be reported in a way that reflects the complex, not the free tripeptide.
5. Named laboratory, dated, with method. Analytical method, column, and the testing laboratory's identity. An unsigned PDF with no method section is decoration.
6. Consistency across lots. Ask for two certificates from different lots. Batch-to-batch reproducibility is the thing that actually predicts your next order.

Storage, handling and origin

Copper complexes are more sensitive to light and oxidative conditions than plain peptides, so opaque or shielded storage and minimal headspace exposure matter more here than for a standard single-peptide vial. Repeated freeze-thaw is a known source of degradation in peptide solutions generally; aliquoting into single-use portions avoids it. Whenever the material is in solution, inspect for particulates and for loss of the blue color before logging it into inventory.

Material in this catalog is synthesized in the UK and verified in US laboratories. Order the smallest quantity that lets you run your own identity and purity confirmation first, then scale.

Regulatory context

This is a research-use-only article, supplied for in-vitro laboratory work. The published work on all three compounds is a body of in-vitro and animal laboratory research under examination, and no conclusions from it are drawn or implied here.

For people operating under anti-doping rules: BPC-157 and TB-500 both appear on the WADA Prohibited List.